Diet drugs are medications that help people lose weight or maintain a healthy weight. Though there are a lot of pills and supplements that claim to help people lose weight, only a handful of medications have been approved by the U.S. Food and Drug Administration for legal sale in the United States.
Overview of Diet Drugs
Diet drugs do not have a good recent history in the United States. In the late 1990s, a popular drug known as "fen-phen" was pulled from the market because of concerns over heart valve damage and lung problems related to its use. Currently, only a few diet drugs are available legally. One is known as orlistat, sold over-the-counter as Alli and with a prescription as Xenical. This drug blocks fat absorption in the intestine to help people lose weight.
In 2012, two new diet drugs gained FDA approval. Both are appetite suppressants: Qsymia and Belviq.
Benefits and Risks
Though these drugs have been shown in studies to help with weight loss, each carries a number of risks. For example, orlistat has been linked to severe liver injury in rare instances. Qsymia might be dangerous for those with heart disease, thyroid disease or glaucoma. Belviq seemed to be safer overall in clinical studies, but it has been linked to heart problems, mood disorders and potentially dangerous interactions with other medications. The overall weight loss from the drug was fairly small as well. None of these drugs are safe for use during pregnancy.
The bottom line appears to be that diet drugs are not a "magic pill" for weight loss, and they are most effective when paired with increased exercise and healthier eating habits. The drugs also pose additional risks for teens, who are still growing and maturing. Most health experts agree that the best path to safe and healthy weight loss is to do so naturally through changes to diet and activity levels.
SOURCES: U.S. Food and Drug Administration; American Academy of Pediatrics
Side effects are one consideration, study says
FDA has warned makers of 8 products containing oxilofrine, or methylsynephrine
Study finds surgery more effective at least two years out
Drug had been previously rejected because of concerns about possible heart problems, birth defects
Drug previously rejected because of possible heart problems, birth defects
Lorcaserin one of three new anti-obesity medications up for review by the FDA
They're more likely to respond to product pitches in e-mails, study shows
Combo of diet, exercise and injections helped non-diabetics shed pounds, study finds
But research on 'fatostatin' is still in early stages
Tesofensine could replace gastric bypass surgery for some patients, researchers say
Pills, supplements have potentially dangerous ingredients, lack warning labels, study finds
Cannabinoid receptor blockers appear to impact rewiring needed for neural development, mouse study shows.
Study finds those given injections of ghrelin showed activity in brain's reward centers
Surprise finding might help doctors slow, reverse damage done by drinking, researcher says
But adverse effects include gastrointestinal problems, anxiety
Study found teens who read weight-loss articles more likely to practice unhealthy behaviors
The LXR protein may tell the body to store up fat
Tips to prevent guests from driving drunk
Program targets eating disorders, body-shaping drug use
Scientists find pathways in how diet drug works
New study backs FDA warning about supplement that's now off the market
League bans popular diet supplement that critics call dangerous
Pounds shed even when Meridia is taken intermittently
Study shows addiction may be a brain disorder